Best stock to buy now
Social distancing is one of the most effective ways to contain the spread of the coronavirus. But it is also the travel industry's worst nightmare. People have been forced to rethink trips within their own cities, not to mention vacations to faraway destinations. The pandemic is hurting the industry far and wide, from airlines to casinos and rental-car companies. Even Warren Buffett, one of the most famous investors, disclosed last weekend that he dumped his entire stake in airline stocks in April. Another indicator of a gradual recovery in travel is investors' demand for newly issued Boeing debt.
Stocks to Buy
Since hitting four-year lows in late March, for instance, the Dow Jones Industrial Average has gained Even so, there are still plenty of amazing bargains to be had in this volatile market.
A select few blue-chip stocks, in fact, are poised to post market-crushing gains over the next decade. Which blue-chip stocks are the best buys right now? Here's why. Berkshire Hathaway is the diversified holding company run by superstar investors Warren Buffett and Charlie Munger. The company's shares didn't perform terribly well during the roughly year-long bull market, but it was never designed to be a red-hot growth vehicle.
Instead, Buffett and Munger's stroke of genius centers on buying defensively oriented stocks that tend to muddle along during bull markets, but that markedly outperform other asset classes during periods of strife. Berkshire's Class B shares, in fact, are trading at a three-year low at the moment. Although Buffett and Munger have said they don't plan on going on a spending spree during the current crisis, their track record of beating the broader markets on a consistent basis cannot be denied.
So if you're looking for a cheap way to gain exposure to some of the best companies in the world and take advantage of the two of the best minds in finance, Berkshire is undoubtedly the way to go. Gilead is the king of infectious disease treatments. The Californian biotech first made a name for itself by developing game-changing treatments for HIV -- a market it still dominates today. After that, Gilead upended the hepatitis C market by bringing functional cures to market such as Sovaldi and Harvoni.
Now the biotech is aiming to bring COVID to its proverbial knees through a once-failed Ebola medication called remdesivir. Last week, a preliminary report emerged that remdesivir is bending the curve on severely ill COVID patients. The study is far from a finished product, but investors are clearly hopeful about the drug's prospects. Remdesivir isn't even the most compelling reason to buy this top biotech stock, however.
Over the last five years, Gilead has amassed one of the largest cash positions in the industry. And with a new CEO at the helm, the company has started to put this cash stockpile to use, evinced by its recent acquisition of the clinical-stage oncology company Forty Seven.
What's more, rumors are swirling that Gilead has eyeballs on two other immuno-oncology companies as well. Put simply, the biotech seems intent on ratcheting up its oncology portfolio through a string of value-creating deals this year. The big picture is that Gilead appears ready to dive head first into the high-value cancer market. Now, this complex transition from an infectious disease giant into to a top oncology company will take a few years to play out.
However, patient investors can sit back and collect the biotech's above average dividend yield of 3. Apr 19, at AM. Author Bio George Budwell has been writing about healthcare and biotechnology companies at the Motley Fool since His primary interests are novel small molecule drugs, next generation vaccines, and cell therapies. Image source: Getty Images. Stock Advisor launched in February of Join Stock Advisor. Related Articles.
NRG Energy Inc. (NRG). ViacomCBS Inc. (VIAC).
Skilled active investment managers now have a huge opportunity to add value, writes Mark Hulbert. Ridesharing company Uber boasts competitive advantages, writes Vitaliy Katsenelson. This market yardstick with a strong track record sees U.
Of all the stocks in the market, which are the top 10 best to buy now?
If you are looking to compare online brokers , take a look at some of our other favorites. New money is cash or securities from a non-Chase or non-J.
2 Best Stocks to Buy Now
When looking for the best stocks, investors should consider long-term performance, not short-term volatility. Are these the best stocks to invest in right now? Not necessarily. For more on index funds, jump to below this list. Picking individual stocks is difficult, which is why many investors turn to index mutual funds and exchange-traded funds, which bundle many stocks together. Likewise, investors can track the DJIA with an index fund tied to that benchmark.
Top 10 Best Stocks To Buy Now
The Canadian cannabis company has long had the ability to generate revenues, but the business has never matched those with viable operating expenses. The company plans a reverse split before the market opens on May 11 to satisfy NYSE listing requirements. Most reverse splits are negative for shareholders, but Aurora Cannabis has the ability to showcase improving trends far outweigh a reverse share split. The only way to reward shareholders is for Aurora Cannabis to report solid revenues while pulling down quarterly operating expenses. The goal is to set the company up for these quarterly expenses by the start of FY21 in July. The cannabis company has to slash this amount to negligible levels via cutting expenses and all but eliminating capital expenditures to survive and thrive. The shareholder impact comes from a lowered stock price causing more dilution to shareholders when the company sells stock to fund ongoing cash burn. As the company should already have visibility into mid-June quarter numbers, the ability to pronounce a solid path to breakeven on an operating basis is key. On top of that, the elimination of nearly all capital expenditures would alleviate crucial cash burn levels.
CNBC's Jim Cramer on Tuesday gave his thoughts on the most sought-after stocks by younger investors on the popular stock trading app Robinhood. The investing platform's co-CEO Vlad Tenev in a " Mad Money " interview the day prior revealed the top stocks that investors bought through the start-up brokerage app in March.
Your browser is not supported. Log In.
Best Stocks Under $5
The coronavirus pandemic has erased all the gains stocks saw in early , officially ending an year bull run. Volatility isn't over, and the impact of the virus on daily life, markets, and the economy is just beginning to be felt. While the fallout from the global COVID outbreak in the coming months could be devastating — an increasing number of confirmed cases, school and business closings, wild market swings — the long-term investing picture is still the same. Global growth will continue. A decline in manufacturing and consumer spending over the next few months will cause growth to slow, but it will not stop completely. It might seem hard to believe, but it's more important than ever to have your "stocks to buy" list polished and ready to go — because what we're being presented with is a generational buying opportunity. Don't worry about trying to time the bottom. Buying now, on the way down and on the way up, means you're still getting in at a lower price than where stocks will eventually go. We don't recommend putting in all your cash at once; instead, buy a little at a time. Even if prices go lower, you're essentially "averaging down" and getting in at a lower cost overall. To get you started, we've identified the seven stocks below as ones with outstanding short-term and long-term profit potential. A third has developed a life-saving technology so vital, we predict it could double your money in the next few years alone.
Best Stocks to Buy Now
Since hitting four-year lows in late March, for instance, the Dow Jones Industrial Average has gained Even so, there are still plenty of amazing bargains to be had in this volatile market. A select few blue-chip stocks, in fact, are poised to post market-crushing gains over the next decade. Which blue-chip stocks are the best buys right now? Here's why.
